4004 Overzicht aandelen
Dallah Healthcare Company is een gezondheidszorgbedrijf in het Koninkrijk Saudi-Arabië. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 1/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 5/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
Dallah Healthcare Company Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | ر.س154.20 |
| 52 Week Hoogtepunt | ر.س194.00 |
| 52 Week Laag | ر.س150.00 |
| Bèta | 0.21 |
| 11 maand verandering | -2.16% |
| 3 maanden verandering | -4.46% |
| 1 Jaar Verandering | -3.99% |
| 33 jaar verandering | 115.66% |
| 5 jaar verandering | 331.33% |
| Verandering sinds IPO | 350.62% |
Recent nieuws en updates
Some Shareholders Feeling Restless Over Dallah Healthcare Company's (TADAWUL:4004) P/E Ratio
Oct 31
The Return Trends At Dallah Healthcare (TADAWUL:4004) Look Promising
Oct 07Do Dallah Healthcare's (TADAWUL:4004) Earnings Warrant Your Attention?
Sep 19Recent updates
Some Shareholders Feeling Restless Over Dallah Healthcare Company's (TADAWUL:4004) P/E Ratio
Oct 31The Return Trends At Dallah Healthcare (TADAWUL:4004) Look Promising
Oct 07Do Dallah Healthcare's (TADAWUL:4004) Earnings Warrant Your Attention?
Sep 19Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 14The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)
Jul 18Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist
May 30We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Apr 16What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E
Mar 18Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes
Feb 25Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward
Oct 30Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return
Jul 26Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)
Apr 17Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Feb 06Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends
Dec 05We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Nov 01Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)
Aug 28Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger
Aug 12Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Jul 28Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%
May 26Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)
May 20Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Apr 16Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Feb 03Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Jan 10Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Oct 19Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Jul 09Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically
Jun 16Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher
May 02What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?
Mar 17Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?
Mar 02Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year
Feb 15Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?
Feb 01Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 05
Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price
Dec 22Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?
Nov 20Rendement voor aandeelhouders
| 4004 | SA Healthcare | SA Markt | |
|---|---|---|---|
| 7D | 0% | 0.2% | -0.01% |
| 1Y | -4.0% | -2.2% | -9.2% |
Rendement versus industrie: 4004 presteerde slechter dan de SA Healthcare -sector, die het afgelopen jaar een rendement van -2.2 % opleverde.
Rendement versus markt: 4004 overtrof de SA markt, die het afgelopen jaar een rendement opleverde van -9.2 %.
Prijsvolatiliteit
| 4004 volatility | |
|---|---|
| 4004 Average Weekly Movement | 2.6% |
| Healthcare Industry Average Movement | 4.2% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in SA Market | 7.6% |
| 10% least volatile stocks in SA Market | 2.6% |
Stabiele aandelenkoers: 4004 heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van 4004 is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1994 | n/a | Ahmad bin Babaeer | www.dallahhealth.com |
Dallah Healthcare Company is een gezondheidszorgbedrijf in het Koninkrijk Saudi-Arabië. Het bedrijf houdt zich bezig met het exploiteren, beheren, uitrusten en ontwikkelen van ziekenhuizen en gezondheidszorgfaciliteiten en medische poliklinieken; en het leveren van mankracht en ondersteunende diensten aan ziekenhuizen en medische centra. Het produceert en distribueert farmaceutische, kruiden- en cosmetische producten en toiletartikelen.
Dallah Healthcare Company Samenvatting
| 4004 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | ر.س15.02b |
| Inkomsten(TTM) | ر.س470.95m |
| Inkomsten(TTM) | ر.س3.20b |
31.9x
Koers/Winstverhouding4.7x
P/S-verhoudingIs 4004 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| 4004 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | ر.س3.20b |
| Kosten van inkomsten | ر.س2.05b |
| Brutowinst | ر.س1.15b |
| Overige uitgaven | ر.س681.86m |
| Inkomsten | ر.س470.95m |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 4.84 |
| Brutomarge | 35.99% |
| Nettowinstmarge | 14.70% |
| Schuld/Eigen Vermogen Verhouding | 51.9% |
Hoe presteerde 4004 op de lange termijn?
Bekijk historische prestaties en vergelijkingDividenden
1.0%
Huidig dividendrendement10%
UitbetalingsratioBetaalt 4004 een betrouwbaar dividend?
Zie 4004 dividendgeschiedenis en benchmarks| Dallah Healthcare dividenddata | |
|---|---|
| Ex Dividend Datum | Nov 18 2024 |
| Betaaldatum dividend | Dec 01 2024 |
| Dagen tot Ex-dividend | 7 days |
| Dagen tot dividendbetaaldatum | 6 days |
Betaalt 4004 een betrouwbaar dividend?
Zie 4004 dividendgeschiedenis en benchmarks